CMAC
Home
Journal Archive
Subscription
About
About
Author Guidelines
Editorial Board
Peer Review
Publishing Ethics
English
Русский
CMAC 2021; 23(3)
Type
Review
Original Article
Sections
Antimicrobial Resistance
Diseases and Pathogens
Personal Experience
Genomic properties in
Achromobacter
spp. strains from cystic fibrosis patients in Russia
Objective. To determine species, sequence-types, antimicrobial resistance and virulence genes in Achromobacter spp. isolates obtained …
Bocharova Y.A.
,
Saviniova T.A.
,
Chaplin A.V.
,
Lyamin A.V.
,
Kondratenko O.V.
,
Polikarpova S.V.
,
Zhilina S.V.
,
Fedorova N.I.
,
Korzhanova M.
,
Mayansky N.A.
,
Chebotar I.V.
Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(3):220-225
10.36488/cmac.2021.3.220-225
PDF
Cite
Mucormycosis: modern diagnostics and treatment, existing problems and new trends in antifungal therapy
Over the last decade, the introduction of new antifungal drugs and diagnostic procedures has improved the prognosis of hematological …
Popova M.O.
,
Rogacheva Yu.A.
Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(3):226-238
10.36488/cmac.2021.3.226-238
PDF
Cite
COVID19 associated pulmonary aspergillosis
The novel coronavirus (COVID-19) pandemic announced by the World Health Organization in March 2020 assigned medical community to the …
Ovsyannikov N.V.
,
Bilevich O.A.
Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(3):239-246
10.36488/cmac.2021.3.239-246
PDF
Cite
Almost two years with COVID-19: some aspects of antibiotic use
The objective of this review was to summarize impact of the widespread administration of antibiotics in treatment algorithms for …
Ortenberg E.A.
Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(3):248-253
10.36488/cmac.2021.3.248-253
PDF
Cite
Mucormycosis following COVID19: clinical case and literature review
Mucormycosis is one of the most aggressive invasive mycoses. The mortality rate of patients with mucormycosis, depending on clinical …
Khostelidi S.N.
,
Zaytsev V.A.
,
Pelikh E.V.
,
Yashina E.V.
,
Rodionova O.N.
,
Bogomolova T.S.
,
Avdeenko Yu.L.
,
Klimko N.N.
Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(3):255-262
10.36488/cmac.2021.3.255-262
PDF
Cite
Susceptibility of clinical
Enterobacterales
and
Pseudomonas aeruginosa
isolates to ceftazidimeavibactam in Russia: multicenter local laboratory databased surveillance
Objective. To assess the in vitro activity of ceftazidime-avibactam against clinical Enterobacterales and Pseudomonas aeruginosa …
Edelstein M.V.
,
Skleenova E.Yu.
,
Trushin I.V.
,
Kuzmenkov A.Yu.
,
Martinovich А.А.
,
Shek E.A.
,
Shajdullina E.R.
,
Avramenko A.A.
,
Vinogradova A.G.
,
Ivanchik N.V.
,
Sukhorukova M.V.
,
Romanov A.V.
,
Mikotina A.V.
,
Azyzov I.S.
,
Dekhnich A.V.
,
Kozlov R.S.
,
and the «CAZ-AVI-disk» Study Group
Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(3):264-278
10.36488/cmac.2021.3.264-278
PDF
Cite
In vitro
activity of biapenem and other carbapenems against Russian clinical isolates of
Pseudomonas aeruginosa
,
Acinetobacter
spp., and
Enterobacterales
Objective. To evaluate in vitro activity of biapenem and other clinically available carbapenems against Russian clinical isolates of …
Kozlov R.S.
,
Azyzov I.S.
,
Dekhnich A.V.
,
Ivanchik N.V.
,
Kuzmenkov A.Yu.
,
Martinovich А.А.
,
Mikotina A.V.
,
Sukhorukova M.V.
,
Trushin I.V.
,
Edelstein M.V.
Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(3):280-291
10.36488/cmac.2021.3.280-291
PDF
Cite
Antimicrobial resistance and antimicrobial therapy modification during COVID19 pandemic in large tertiary hospital
Objective. assessment of the evolution of the microbiological landscape of the hospital for the period of operation in 2020 into a …
Romashov O.M.
,
Ni O.G.
,
Bykov A.O.
,
Kruglov A.N.
,
Protsenko D.N.
,
Tyurin I.N.
Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(3):293-303
10.36488/cmac.2021.3.293-303
PDF
Cite
Genetic diversity of vancomycinresistant
Enterococcus faecium
isolated from blood culture in patients with hematological malignancies
Objective. To study the genetic diversity of vancomycin-resistant Enterococcus faecium (VR-E. faecium) isolated from the blood culture …
Khrulnova S.A.
,
Klyasova G.A.
,
Fedorova A.V.
,
Frolova I.N.
,
Biderman B.V.
Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(3):305-313
10.36488/cmac.2021.3.305-313
PDF
Cite
Safety profile assessment of drug products used for the pathogenetic treatment of COVID19
Objective. To review and summarize literature data in studies of safety of the drug products used for the pathogenetic treatment of …
Syraeva G.I.
,
Mishinova S.A.
,
Kolbin A.S.
,
Eremenko E.O.
Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(3):314-329
10.36488/cmac.2021.3.314-329
PDF
Cite
Assessment of biofilmforming activity of
Fusarium solani
isolated from patients’ skin
Objective. To study pathogenic factors (adhesion and biofilm formation) in F. solani isolated from skin of patients Materials and …
Valieva R.I.
,
Lisovskaya S.A.
,
Isaeva G.Sh.
Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(3):330-336
10.36488/cmac.2021.3.330-336
PDF
Cite
Cite
×
